Dr. Reddy’s settles dispute with Indivior, to receive $72m
As part of the settlement, the underlying litigation will be dismissed, the Hyderabad-headquartered drugmaker said. As part of the settlement, the underlying litigation will be dismissed, the Hyderabad-headquartered drugmaker said. Pharma major Dr. Reddy’s Laboratories has entered into settlement agreement with British drugmaker Indivior resolving patent litigation relating to latter’s opioid dependence treatment drug Suboxone. […]
Continue Reading
